María Socorro Parra-Cabrera

Dr. María Socorro Parra-Cabrera

Auto-generated profile, based on publicly available information

Dr. María Socorro Parra-Cabrera


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2002 in Public Health Nutrition
Verified
Journal Article
Closed access
MPMaria-Socorro Parra
Maria-Socorro Parra
LSLourdes Schnaas
Lourdes Schnaas
MMMohsen Meydani
Mohsen Meydani
EPEstela Perroni
Estela Perroni
SMSandra Martíanez
Sandra Martíanez
IRIsabelle Romieu
Isabelle Romieu
Objective: To evaluate the validity of a food-frequency questionnaire (FFQ) for assessment of the dietary intakes of polyunsaturated fatty acids (PUFAs) against a biochemical marker of fat intake, erythrocyte cell membrane phospholipid levels, during pregnancy.Design: Cross-sectional analysis.Setting: Developmental Neurobiology Department, National Institute of Perinatology, Mexico City.Subjects: One hundred forty-six healthy pregnant women during the last trimester of pregnancy. Among women enrolled, the first 35 pregnant women (24%) had their erythrocytes analysed for fatty acid status.Methods: We administered an FFQ and compared intakes of PUFAs against their erythrocyte cell membrane concentrations, processed by gas chromatography.Results: Pearson correlation coefficients among α-linolenic acid (ALN), docosahexaenoic acid (DHA) and eicosapentaenoic acid in erythrocyte cell membranes against their crude dietary counterparts were 0.32, 0.35 and 0.36 (each P < 0.05). In a simple linear regression, erythrocyte DHA and arachidonic acid (AA) were significantly related to their respective dietary intakes (β = 0.30, 95% confidence interval (CI): 0.007–0.60, P = 0.045 for DHA; β = 0.49, 95% CI: 0.010–0.98, P = 0.044 for AA). Erythrocyte cell membrane ALN concentration (%/total) was only marginally related to ALN dietary intake (mg day−1) (β = 0.52, 95% CI: −0.020–1.10, P = 0.061). However, after adjustment for long-chain n–3 PUFA/AA, this association reached significance (β = 0.44, 95% CI: 0.026–0.825, P = 0.038). Main dietary sources for n–3 PUFAs were canned tuna fish and fresh catfish; for n–6 these were eggs and cow's milk. The use of this FFQ in these pregnant Mexican women provided estimates of average long-term intakes of PUFAs and correlated reasonably well with their erythrocyte cell membrane phospholipid status. However, we need to consider that, during pregnancy, there is a faster turnover of PUFAs from fat storage that may modify the profile of erythrocyte PUFAs and lower the correlation between dietary intake and erythrocyte PUFAs.

2 March 2023 in Foods
Verified
Journal Article
Open access
PDF file
AAAlexis Alonso-Bastida
Alexis Alonso-Bastida
MMManuel Adam Medina
Manuel Adam Medina
ASAzucena Salazar-Piña
Azucena Salazar-Piña
RJRicardo Fabricio Escobar Jiménez
Ricardo Fabricio Escobar Jiménez
MPMaría-Socorro Parra-Cabrera
María-Socorro Parra-Cabrera
MCMarisol Cervantes-Bobadilla
Marisol Cervantes-Bobadilla
This work presents an analysis of the effect on glycemic variation caused by modifying the macronutrient intake sequence in a person without a diagnosis of diabetes. In this work, three types of nutritional studies were developed: (1) glucose variation under conditions of daily intake (food mixture); (2) glucose variation under conditions of daily intake modifying the macronutrient intake sequence; (3) glucose variation after a modification in the diet and macronutrient intake sequence. The focus of this research is to obtain preliminary results on the effectiveness of a nutritional intervention based on the modification of the sequence of macronutrient intake in a healthy person during 14-day periods. The results obtained corroborate the positive effect on the glucose of consuming vegetables, fiber, or proteins before carbohydrates, decreasing the peaks in the postprandial glucose curves (vegetables: 113–117 mg/dL; proteins: 107–112 mg/dL; carbohydrates: 115–125 mg/dL) and reducing the average levels of blood glucose concentrations (vegetables: 87–95 mg/dL; proteins: 82–99 mg/dL; carbohydrates: 90–98 mg/dL). The present work demonstrates the preliminary potential of the sequence in the macronutrient intake for the generation of alternatives of prevention and solution of chronic degenerative diseases, improving the management of glucose in the organism and permeating in the reduction of weight and the state of health of the individuals.

22 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MRMarta Elena Rivera
Marta Elena Rivera
MFMario Flores-Aldana
Mario Flores-Aldana
MPMaría-Socorro Parra-Cabrera
María-Socorro Parra-Cabrera
AQAmado D. Quezada-Sánchez
Amado D. Quezada-Sánchez
AGArmando García-Guerra
Armando García-Guerra
Jorge Maldonado-HernándezJorge Maldonado-Hernández
Jorge Maldonado-Hernández
Background: Polyunsaturated fatty acids (PUFAs) are essential to child growth and development. Objective: To assess the effect of PUFAs-fortified infant formula on lipid profile, growth and micronutrient status in children 12 to 30 months old. Methods: This study is a double-blind randomized controlled clinical trial. Two study groups were assessed: (a) milk-based infant formula with micronutrients and PUFAs (PUFAs) and (b) milk-based infant formula with micronutrients, no PUFAs added (Non-PUFAs). Children received prepared formula (240 mL) twice a day, according to the color-code assigned to each infant. Anthropometric measurements and venous blood samples were taken at each day-care center at baseline, and again after four months. Total serum lipid extraction was 0.5 mL. Samples were treated and modified by the Folch method and analyzed with gas chromatography. Results: Changes in serum lipid profile (expressed as % FA) between baseline and four months showed a statistically significant increase in docosahexaenoic acid (DHA) (0.22 vs. −0.07, p < 0.05) and Alpha-Linoleic acid (0.08 vs. 0.02, p < 0.05) in infants who consumed PUFAs-fortified formula compared to Non-PUFAs-fortified formula. Infants increased their length/height-for-age Z-score: median change for the PUFAs group was 0.16 (95% CI = 0.08, 0.28) and 0.23 (95% CI = 0.14, 0.33) for Non-PUFAs, with no differences between groups. Median folate level was significantly higher among the PUFAs group compared to Non-PUFAs: −0.87 (95% CI = −1.38, −0.44) and −3.83 (95% CI = −4.65, −3.03) respectively. Consumption of both supplements was adequate and stable during the intervention. Conclusion: A significant improvement was observed in the lipid profile of children who received the PUFAs-fortified milk-based formula.

14 January 2021 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
ESEduardo Salazar-Martínez
Eduardo Salazar-Martínez
JHJosé Ángel Hernández-Mariano
José Ángel Hernández-Mariano
MPMarcia Verónica Portillo
Marcia Verónica Portillo
MBMary Carmen Baltazar-Reyes
Mary Carmen Baltazar-Reyes
MPMaría Socorro Parra-Cabrera
María Socorro Parra-Cabrera
LCLea Aurora Cupul-Uicab
Lea Aurora Cupul-Uicab
Objetivo. Resumir la evidencia científica sobre las altera­ciones renales asociadas con la infección por SARS-CoV-2. Material y métodos. Se realizó una revisión rápida con la metodología Cochrane. Resultados. La enfermedad renal crónica (ERC) preexistente en pacientes con SARS-CoV-2 varió de 1 a 38% y la lesión renal aguda (LRA), de 2.9 a 86.4%. El pronóstico de la infección fue peor en pacientes con ERC y en aquellos con reserva renal remanente (RRR) intacta que desarrollaron LRA. El riesgo de muerte fue mayor (riesgo relativo combinado = 1.49; IC95%: 1.09-2.04) en pacientes infectados por SARS-CoV-2 con ERC preexistente. Los mar­cadores de RRR mostraron alteraciones en pacientes con SARS-CoV-2 graves y fatales; el marcador más utilizado fue la creatinina sérica. Conclusiones. La evidencia científica muestra la relevancia de la evaluación y monitoreo perma­nente de la RRR en pacientes hospitalizados por SARS-CoV-2 para mejorar el pronóstico de aquellos con ERC preexistente, así como de aquellos sin ERC que desarrollan LRA.

5 November 2024 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
MPMaría Socorro Parra-Cabrera
María Socorro Parra-Cabrera
JDJose Zaim Delgado-Ramírez
Jose Zaim Delgado-Ramírez
AÁAngélica Rocío Ángeles–Llerenas
Angélica Rocío Ángeles–Llerenas
EHErika Hurtado-Salgado
Erika Hurtado-Salgado
IHIgnacio Méndez Gómez Humarán
Ignacio Méndez Gómez Humarán
Objective. To analyze the association between gestational weight gain in women with gestational diabetes and an increased risk of macrosomia. Materials and methods. Cohort study with 139 pregnant women screened by a single-step oral glucose tolerance curve between 24-28 weeks of gestation were confirmed with gestational diabetes and sent to a hospital. Pre-pregnancy body mass index (BMI) was calculated from pre-pregnancy weight. Weight was measured at each prenatal consultation. The reference category was women with normal prenatal BMI who gained appropriate weight during pregnancy. At each visit, medical nutrition therapy (MNT) consisted of nutritional counseling, physical activity plan, and insulin therapy. Compliance with MNT was measured by capillary glucose measurements taken by each participant at home. Results. 74.8% were primiparous, and 28.8% had normal pre-pregnancy BMI. The no linear logistic regression model showed women with normal pre-pregnancy BMI had twice (OR= 2.08, 95%CI: 1.07,4.05) the possibility of macrosomia, compared to mothers with overweight or obesity, adjusting for Capurro index, number of children in the family, and percent of compliance MNT. Macrosomia was the most prevalent childhood complication (12.3%). Conclusion. Women with normal pre-pregnancy BMI who gained more weight during pregnancy were at higher risk of having macrosomic infants.

14 January 2026 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
MPMaría Socorro Parra-Cabrera
María Socorro Parra-Cabrera
EHErika Marlen Hurtado-Salgado
Erika Marlen Hurtado-Salgado
EMEric Monterubio-Flores
Eric Monterubio-Flores
IHIgnacio Méndez Gómez Humarán
Ignacio Méndez Gómez Humarán
LCLea Aurora Cupul-Uicab
Lea Aurora Cupul-Uicab
Objective. To assess the association between glucose control during pregnancy and infant’s growth. Materials and methods. Prospective study of 130 women with gestational diabetes mellitus (GDM) followed up to three months after birth. Infant’s growth was assessed as weight-for-age (WfA), weight-for-length (WfL), and length-for-age (LfA) z-scores. The association of adequate vs. inadequate glucose control with infant’s growth was evaluated using linear mixed models. Results. Overall, glucose control during pregnancy was not associated with WfA (aβ= 0.089; 95%CI: -0.248,0.426), WfL (aβ= 0.006; 95%CI: -0.280,0.291), and LfA (aβ= 0.136; 95%CI: -0.157,0.429). We observed heterogeneity of effects by gestational age; infants with adequate control compared to inadequate had reduced WfA if they were born at ≥39 weeks. Conclusion. Glucose control of women with GDM might have little impact on their early offspring’s growth; however, gestational age might be relevant in terms of heterogeneity of effects. Future studies to confirm the latter findings are required.